MASScot does not endorse nor is affiliated with any of the content contained within these links.
- Merck halts study in light of melanoma drug’s success
Keytruda proved successful in prolonging survival rates of melanoma patients, and the company is hoping the drug can do the same for many more cancers.
Source: Fortune
- Combined Triple Therapy Boosts Anti-Tumor Immune Response in Melanoma
In a new study entitled “Improved anti tumor activity of immunotherapy with BRAF and MEK inhibitors in BRAFV600E melanoma,” researchers show increased anti-tumor activity of a triple therapy – BRAF and MEK inhibitors with immunotherapy — in BRAF mutant melanoma. The study was published in the journal Science Translational Medicine.
Source: Immuno-Oncology News
- Teacher determined to educate about dangers of melanoma
One in five Americans will develop skin cancer in their lifetime and 3.5 million new cases are predicted to be diagnosed this year, that’s according to IU Health.
Biology teacher Ken Link knows the statistics all too well. He lost his wife to skin cancer two years ago.
It’s one reason why he makes sure Hamilton Southeastern High School students know the dangers of the sun.
Source: Wish TV
- Research Shows Gene Removal May Aid Melanoma Treatmen
Nearly 10,000 deaths from melanoma – the deadliest of all skin cancers – occurred in the U.S. last year, according to the National Cancer Institute. And while treatment advances have been made in fighting melanoma, a majority of these patients will die from their disease. In an aim to build upon these advances, investigators at Rutgers Cancer Institute of New Jersey have demonstrated that removal of a gene involved in the cellular self-cannibalization process of autophagy could provide therapeutic benefit to patients with melanoma.
Source: NewsWise
Source: Healio
A triple attack of radiation plus two immunotherapies appears to improve the immune system response in patients with metastatic melanoma, according to a recent study from a multidisciplinary team of researchers, including the Miller School’s Hemant Ishwaran, Ph.D., professor of public health sciences.
Source: Health Canal
When actress Emilia Fox was pregnant with her daughter Rose she felt the same joyous Wanticipation as any woman about to become a mother for the first time. But just as the 40-year-old Silent Witness star was mapping out her future as a parent she faced a health scare which threatened all her dreams.
Source: Express
Researchers at the Magdeburg University Clinic for Dermatology and Venereology in Germany and colleagues have developed a full-body scanner device that could bring early detection of skin cancer a major step forward, as it could simplify the work of dermatologists and provide a more reliable form of skin screening.
Source: Bio Optics World
Source: NewsWise
- Ipilimumab confers long-term survival in advanced melanoma
Source: Healio
- Radiation Plus Immunotherapy Combination Improves Immune System Response to Metastatic Melanoma
A triple attack of radiation plus two immunotherapies appears to improve the immune system response in patients with metastatic melanoma, according to a recent study from a multidisciplinary team of researchers, including the Miller School’s Hemant Ishwaran, Ph.D., professor of public health sciences.
Source: Health Canal
- Skin cancer scare has made me more aware of sun dangers, says Emilia Fox
When actress Emilia Fox was pregnant with her daughter Rose she felt the same joyous Wanticipation as any woman about to become a mother for the first time. But just as the 40-year-old Silent Witness star was mapping out her future as a parent she faced a health scare which threatened all her dreams.
Source: Express
- Full-body scanner could ease early detection of skin cancer
Researchers at the Magdeburg University Clinic for Dermatology and Venereology in Germany and colleagues have developed a full-body scanner device that could bring early detection of skin cancer a major step forward, as it could simplify the work of dermatologists and provide a more reliable form of skin screening.
Source: Bio Optics World
No comments:
Post a Comment